только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 10 / 14
Страница 2 / 3

Список литературы

Внимание! Часть функций, например, копирование текста к себе в конспект, озвучивание и т.д. могут быть доступны только в режиме постраничного просмотра.Режим постраничного просмотра

Ивашкин В. Т., Шелыгин Ю. А., Абдулганиева Д. И., Абдулхаков Р. А., Алексеева О. П., Ачкасов С. И., Барановский А. Ю., Белоусова Е. А., Головенко О. В., Григорьев Е. Г., Костенко Н. В., Лапина Т. Л., Маев И. В., Москалёв А. И., Низов А. И., Николаева Н. Н., Осипенко М. Ф., Павленко В. В., Парфенов А. И., Полуэктова Е. А., Румянцев В. Г., Тимербулатов В. М., Тертычный А. С., Ткачёв А. В., Трухманов А. С., Халиф И. Л., Хубезов Д. А., Чашкова Е. Ю., Шифрин О. С., Щукина О. Б. Рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых больных язвенным колитом. Российский журнал гастроэнтерологии гепатологии и колопроктологии 2015; 25(1):48-65.

Ивашкин В. Т., Шелыгин Ю. А., Абдулганиева Д. И., Абдулхаков Р. А., Алексеева О. П., Ачкасов С. И., Барановский А. Ю., Белоусова Е. А., Головенко О. В., Григорьев Е. Г., Костенко Н. В., Низов А. А., Николаева Н. Н., Осипенко М. Ф., Павленко В. В., Парфёнов А. И., Полуэктова Е. А., Румянцев В. Г., Тимербулатов В. М., Ткачёв А. В., Халиф И. Л., Хубезов Д. А., Чашкова Е. Ю., Шифрин О. С., Щукина О. Б. Рекомендации Российской гастроэнтеро-логической ассоциации и Ассоциации колопроктологов России по диагностике и лечению взрослых пациентов с болезнью Крона. http://www.gastro.ru/.

Корнеева О. Н., Ивашкин В. Т. Антибиотикоассоциированный колит: патоморфология, клиника, лечение. Российский журнал гастроэнтерологии гепатологии и колопроктологии 2007; 17(3):65-70.

Лобзин Ю. В., Захаренко С. М., Иванов Г. А. Современные представления об инфекции Clostridium difficile. Клиническая микробиология и антимикробная терапия, № 3, Том 4, 2002, С. 200-232.

Рациональная фармакотерапия заболеваний органов пищеварения / Под ред. В. Т. Ивашкина. М.: Литтерра, 2011; 522-6.

Шептулин А. А. Рефрактерные и рецидивирующие формы колита, ассоциированного с Clostridium difficile. Российский журнал гастроэнтерологии гепатологии и колопроктологии 2011; 21(2):50-3.

Wright Donna F .R. Largest ever European clinician consensus report on Clostridium difficile infection provides recommendations for improved management of CDI pressemitteilung astellas EMEA. 2014.

Shah D. N. et al. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. // J. Hosp. Infect. Elsevier, 2016. Vol. 93, № 3. P. 286-289.

McFarland L. V. Emerging therapies for Clostridium difficile infections // Expert Opin. Emerg. Drugs. Taylor & Francis, 2011. Vol. 16, № 3. P. 425-439.

Kutty P. Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA // CME. 2010.

Knight D. R. et al. Diversity and evolution in the genome of clostridium difficile // Clin. Microbiol. Rev. 2015. Vol. 28, № 3. P. 721-741.

Tschudin-Sutter S. et al. Growth Patterns of Clostridium difficile Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study // PLoS One. 2016. Vol. 11, № 9. P. e0161711.

Judith A.; Brien et al. The emerging infectious challenge of Сlostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. // Infect. Control & Hosp. Epidemiol. Cambridge University Press, 2007. Vol. 28, № 11. P. 1219-1227.

Arimoto J. et al. Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: Systematic review and meta-analysis // Sci. Rep. Nature Publishing Group, 2016. Vol. 6. P. 29754

Na X. et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection // PLoS One. 2015. Vol. 10, № 4.

Kurti Z. et al. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. // World J. Gastroenterol. 2015. Vol. 21, № 21. P. 6728-6735.

Kazanowski M. et al. Clostridium difficile: Epidemiology, diagnostic and therapeutic possibilities - A systematic review // Tech. Coloproctol. 2014. Vol. 18, № 3. P. 223-232.

Hassan S.A. et al. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards // J. R. Coll. Physicians Edinb. 2013. Vol. 43, № 2. P. 103-107.

Martin J., Monaghan T., Wilcox M. H. Clostridium difficile infection: advances in epidemiology, diagnosis and understanding of transmission. // Nat. Rev. Gastro. Hep. Nature Publishing Group, 2016. Vol. In press

Na X. et al. A multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection // PLoS One. 2015. Vol. 10, № 4.

Benedek O., Podbielski A., Warnke P. Laboratory experience with the liaison analyzer in the diagnosis of Clostridium difficile -associated diarrhea // Eur. J. Microbiol. Immunol. 2016. Vol. 6, № 3. P. 215-218.

Turgeon D. K. et al. Six Rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay // J. Clin. Microbiol. 2003. Vol. 41, № 2. P. 667-670.

Yoldas O. et al. A diagnostic algorithm for the detection of Clostridium difficile-associated diarrhea // Balkan Med. J. 2016. Vol. 33, № 1. P. 80-86.

Russello G. et al. Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates. // New Microbiol. 2012. Vol. 35. P. 307-316.

Beneš J. et al. [Diagnosis and therapy of Clostridium difficile infection: Czech national guidelines]. // Klin. Mikrobiol. Infekc. Lek. 2014. Vol. 20, № 2. P. 56-66.

LaSala P. R. et al. Comparison of analytical and clinical performance of three methods for detection of Clostridium difficile // Arch. Pathol. Lab. Med. College of American Pathologist 325 Waukegan Rd, Northfield, IL 60093, 2012. Vol. 136, № 5. P. 527-531.

Johansson K., Karlsson H., Norén T. Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples // APMIS. 2016. Vol. 124, № 11. P. 1016- 1020.

Fenner L. et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile // J. Clin. Microbiol. Am. Soc. Microbiol., 2008. Vol. 46, № 1. P. 328-330.

Burnham C.-A. D., Carroll K. C. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. // Clin. Microbiol. Rev. American Society for Microbiology, 2013. Vol. 26, № 3. P. 604-630.

Moon H.-W. et al. Comparison of diagnostic algorithms for detecting toxigenic Clostridium difficile in routine practice at a tertiary referral hospital in Korea // PLoS One. 2016. Vol. 11, № 8. P. e0161139.

Kachrimanidou M., Malisiovas N. Clostridium difficile Infection: A comprehensive review // Crit. Rev. Microbiol. 2011. Vol. 37, № 3. P. 178-187.

Collins D. А., Elliott B., Riley T. V. Molecular methods for detecting and typing of Clostridium difficile // Pathology. 2015. Vol. 47, № 3. P. 211-218.

Ananthakrishnan A. N., Issa M., Binion D. G. Clostridium difficile and inflammatory bowel disease // Med. Clin. North Am. Elsevier Ltd, 2010. Vol. 94, № 1. P. 135-153.

Binnicker M. J. Multiplex molecular panels for diagnosis of gastrointestinal infection: Performance, result interpretation, and cost-effectiveness // J. Clin. Microbiol. 2015. Vol. 53, № 12. P. 3723-3728.

Cunningham S. A. et al. Three-hour molecular detection of Campylobacter, Salmonella, Yersinia and Shigella species in feces with accuracy as high as that of culture // J. Clin. Microbiol. 2010. Vol. 48, № 8. P. 2929-2933.

Karre T. et al. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection // J. Clin. Microbiol. 2011. Vol. 49, № 2. P. 725-727.

Buckwalter S. P. et al. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources // J. Clin. Microbiol. 2012. Vol. 50, № 3. P. 766-771.

Buss S. N. et al. Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis // J. Clin. Microbiol. 2015. Vol. 53, № 3. P. 915-925.

Kapusinszky B., Minor P., Delwart E. Nearly constant shedding of diverse enteric viruses by two healthy infants // J. Clin. Microbiol. 2012. Vol. 50, № 11. P. 3427-3434.

Mattila E. et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial // Scand. J. Infect. Dis. Taylor & Francis, 2008. Vol. 40, № 9. P. 702-708.

Aguado J. M. et al. Highlighting clinical needs in Clostridium difficile infection: the views of European healthcare professionals at the front line. // J. Hosp. Infect. Elsevier, 2015. Vol. 90, № 2. P. 117-125.

Turgeon D. K. et al. Six Rapid Tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay // J. Clin. Microbiol. 2003. Vol. 41, № 2. P. 667-670.

Le R., Wallet G. F. Laboratory diagnosis of Clostridium difficile infection // Ann. Biol. Clin. Synthèse Ann Biol Clin. 2013. Vol. 71, № 714. P. 395-400.

Martin-Verstraete I., Peltier J., Dupuy B. The regulatory networks that control Clostridium difficile toxin synthesis // Toxins (Basel). 2016. Vol. 8, № 5. P. 1-24.

Bomers M. K. et al. Using a dog’s superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study // Bmj. 2012. Vol. 345, P. e7396.

Maurer M. et al. Detection of bacteriuria by canine olfaction // Open Forum Infect. Dis. 2016. Vol. 3, № 2. P. ofw051.

Novais R. C., Thorstenson Y. R. The evolution of Pyrosequencing?? for microbiology: From genes to genomes // J. Microbiol. Methods. Elsevier B. V., 2011. Vol. 86, № 1. P. 1-7.

Ley R. E., Peterson D. A., Gordon J. I. Ecological and evolutionary forces shaping microbial diversity in the human intestine // Cell. 2006. Vol. 124, № 4. P. 837-848.

Yoon S. S., Kim E. K., Lee W. J. Functional genomic and metagenomic approaches to understanding gut microbiota-animal mutualism // Curr. Opin. Microbiol. Elsevier Ltd, 2015. Vol. 24. P. 38-46.

Brown J. H. et al. Translating the human microbiome // Nat. Biotechnol. Nature Publishing Group, 2013. Vol. 31, № 4. P. 304-308.

Martín R. et al. The role of metagenomics in understanding the human microbiome in health and disease. // Virulence. 2014. Vol. 5, № 3. P. 413-423.

Kostic A. D., Xavier R. J., Gevers D. The Microbiome in iflammatory bowel diseases: current status and the future ahead // Gastroenterology. 2015. Vol. 146, № 6. P. 1489-1499.

Norman J. M. et al. Disease-specific Alterations in the enteric virome in inflammatory bowel disease // NIH Public Access. 2016. Vol. 160, № 3. P. 447-460.

Qin J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes // Nature. Nature Publishing Group, 2012. Vol. 490, № 7418. P. 55-60.

Karre T. et al. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection // J. Clin. Microbiol. 2011. Vol. 49, № 2. P. 725-727.

Buckwalter S. P. et al. Real-time qualitative PCR for 57 human adenovirus types from multiple specimen sources // J. Clin. Microbiol. 2012. Vol. 50, № 3. P. 766-771.

Benedek O., Podbielski A., Warnke P. Laboratory experience with the liaison analyzer in the diagnosis of Clostridium difficile -associated diarrhea // Eur. J. Microbiol. Immunol. 2016. Vol. 6, № 3. P. 215-218.

Hassan S. A. et al. Hospital-acquired Clostridium difficile infection among patients with type 2 diabetes mellitus in acute medical wards // J. R. Coll. Physicians Edinb. 2013. Vol. 43, № 2. P. 103-107.

Martin J., Monaghan T., Wilcox M. H. Clostridium difficile infection: advances in epidemiology, diagnosis and understanding of transmission. // Nat. Rev. Gastro. Hep. Nature Publishing Group, 2016. Vol. In press.

A practical guidance document for the laboratory detection of toxigenic Clostridium difficile.-Washington, DC: American Society for Microbiology, 2010. -Режим доступа: http: // www.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf.